Edition:
United Kingdom

Digirad Corp (DRAD.OQ)

DRAD.OQ on NASDAQ Stock Exchange Global Market

1.65USD
15 Jun 2018
Change (% chg)

$-0.05 (-2.94%)
Prev Close
$1.70
Open
$1.70
Day's High
$1.70
Day's Low
$1.65
Volume
3,572
Avg. Vol
8,171
52-wk High
$4.40
52-wk Low
$1.25

Chart for

About

Digirad Corporation provides healthcare solutions. The Company's segments include Diagnostic Services, Mobile Healthcare, Diagnostic Imaging and Medical Device Sales and Services. Through Diagnostic Services, the Company offers an imaging services program as an alternative to purchasing equipment or outsourcing the procedures to... (more)

Overall

Beta: 1.95
Market Cap(Mil.): $51.94
Shares Outstanding(Mil.): 19.98
Dividend: 0.05
Yield (%): 8.46

Financials

  DRAD.OQ Industry Sector
P/E (TTM): -- 148.43 32.75
EPS (TTM): -0.16 -- --
ROI: -3.78 9.37 14.38
ROE: -5.01 14.69 16.07

BRIEF-Digirad Corp Q1 Adjusted Non-GAAP Loss Per Share $0.07 From Continuing Operations

* ORATION REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2018

01 May 2018

BRIEF-Digirad Says CFO Jeffry Keyes Notified Co That He Will Resign From All Positions With Co, Effective April 10, 2018

* DIGIRAD SAYS ON MARCH 30, CFO JEFFRY KEYES NOTIFIED CO THAT HE WILL RESIGN FROM ALL POSITIONS WITH CO, EFFECTIVE APRIL 10, 2018 - SEC FILING

03 Apr 2018

BRIEF-Digirad Corp Posts Q4 Loss Of $1.10 Per Share

* ORATION REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND TWELVE MONTHS ENDED DECEMBER 31, 2017

23 Feb 2018

BRIEF-Digirad, East Hill File Preliminary Proxy Statement Related To Aviragen, Vaxart Proposed Merger

* DIGIRAD, EAST HILL FILE PRELIMINARY PROXY STATEMENT RELATED TO AVIRAGEN THERAPEUTICS, VAXART PROPOSED MERGER - SEC FILING

19 Jan 2018

Earnings vs. Estimates